Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy

Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy

<p>Background</p> <p>Inhibitor of DNA binding 1 (Id1) and 3 (Id3) genes have been related with the inhibition of cell differentiation, cell growth promotion and tumor metastasis. Recently, Id1 has been identified as an independent prognostic factor in patients with lung adenocarcin...

Full description

Bibliographic Details
Main Authors: Castañon Eduardo, Bosch-Barrera Joaquim, López Inés, Collado Víctor, Moreno Marta, López-Picazo José María, Arbea Leire, Lozano María Dolores, Calvo Alfonso, Gil-Bazo Ignacio
Format: Article
Language:English
Published: BMC 2013-01-01
Series:Journal of Translational Medicine
Subjects:
Non-small cell lung cancer
Chemoradiotherapy
Id1
Id3
Protein expression
Prognosis
Online Access:http://www.translational-medicine.com/content/11/1/13

Internet

http://www.translational-medicine.com/content/11/1/13

Similar Items